What is it about?
This article “Phosphodiesterase Inhibitors for Diabetes: From Mechanistic Insights to Therapeutic Innovations” is a comprehensive review (currently in press) that explores how drugs known as phosphodiesterase inhibitors (PDEIs) are being investigated for use in diabetes. You will explore to know about new innovation and great knowledge.
Featured Image
Photo by Towfiqu barbhuiya on Unsplash
Why is it important?
The article "Phosphodiesterase Inhibitors for Diabetes: From Mechanistic Insights to Therapeutic Innovations" is important because it highlights a promising, underutilized therapeutic strategy that could go beyond current diabetes treatments. Example- 1. Addresses More Than Just Blood Sugar 2. Potential to Treat Complications 3. Mechanistic Innovation 4. Translational & Clinical Potential 5. Challenges the Status Quo
Perspectives
Writing this article was a great pleasure as it has co-authors with whom I have had long standing collaborations. This article also lead to rare disease groups contacting me and ultimately to a greater involvement in rare disease research.
Aman Chaudhary
Rajiv Academy for Pharmacy
Read the Original
This page is a summary of: Phosphodiesterase Inhibitors for Diabetes: From Mechanistic Insights to Therapeutic Innovations, New Emirates Medical Journal, February 2025, Bentham Science Publishers,
DOI: 10.2174/0102506882344901241218070917.
You can read the full text:
Resources
Contributors
The following have contributed to this page
